Results 81 to 90 of about 3,430 (160)

Challenges and solutions in the development of vaccines against emerging and neglected infectious diseases

Human Vaccines & Immunotherapeutics, 2019
Emerging and emergent infectious diseases (EIDs) represent a significant and growing cause of morbidity and mortality with increased potential for pandemics due to globalization and international trade.
Joel N. Maslow
doaj   +1 more source

Oropouche Virus (OROV): Expanding Threats, Shifting Patterns, and the Urgent Need for Collaborative Research in Latin America

Viruses
Recent outbreaks of Oropouche virus (OROV) in Latin America demonstrate shifting epidemiological trends, with increasing clinical severity and geographic expansion driven by environmental and anthropogenic factors, many of which remain uncertain.
André Ricardo Ribas Freitas, David A. Schwartz, Antônio Silva Lima Neto, Rosana Rodrigues, Luciano Pamplona Goes Cavalcanti, Pedro María Alarcón-Elbal   +5 more
doaj   +1 more source

Production of bunyavirus pseudotyped virus v1

Several Bunyavirales families have been listed as being of high pandemic or epidemic risk by the WHO R&D Blueprint. To supportpandemic preparedness and the 100 Days Mission, along with rapid provision of vaccines and therapeutics, the development of tools to assess the immune response is required.
Giada Mattiuzzo, Emma Bentley, Federica Marchesin   +2 more
openaire   +1 more source

A Novel Bunyavirus in China

New England Journal of Medicine, 2011
Chang-jun, Bao, Xian, Qi, Hua, Wang
openaire   +4 more sources

Copying the bunyavirus genome [PDF]

Nature Reviews Microbiology, 2015
openaire   +1 more source

A system to rapidly develop a bunyavirus pseudotyped virus neutralisation assay for pandemic preparedness. [PDF]

NPJ Vaccines
Marchesin F, Bentley EM, Mutuku F, Jeza V, Ndenga B, Kempster S, Dowall SD, Almond N, Wright E, Banyard AC, Buczkowski H, Elaldi N, Mirazimi A, Hewson R, Rose NJ, Takeuchi Y, Mattiuzzo G.   +16 more
europepmc   +1 more source

Production of bunyavirus pseudotyped virus v2

Several Bunyavirales families have been listed as being of high pandemic or epidemic risk by the WHO R&D Blueprint. To supportpandemic preparedness and the 100 Days Mission, along with rapid provision of vaccines and therapeutics, the development of tools to assess the immune response is required.
Giada Mattiuzzo, Emma Bentley, Federica Marchesin   +2 more
openaire   +1 more source

Structural insight into RNA encapsidation by the severe fever with thrombocytopenia syndrome virus nucleocapsid protein. [PDF]

mBio
Wang Y, Wu H, Sun J, Kuang W, Wang H, Ning Y-J, Deng Z.   +6 more
europepmc   +1 more source

Discovery and molecular identification of a new orthophasmavirus in the Asian citrus psyllid (<i>Diaphorina citri</i>). [PDF]

Front Microbiol
Zhang S, Chen J, Liu L, Xie Z, Liang J, Yan F, Song Y, Wang X, Zhou C, Cao M, Liu J.   +10 more
europepmc   +1 more source

Leveraging Classical Virology and High Throughput Sequencing for Viral Discovery Using a Historical Viral Collection. [PDF]

Viruses
Sistrom M, Neave M, Joseph A, Newberry K, Andrews H, Shilton C, Bhardwaj V, Weir R.   +7 more
europepmc   +1 more source